BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
The Miscellaneous Tariff Bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH V SCHWAN | Deputy Chief of Staff, U.S. Dept of Commerce |
Health Issues HCR
H.R. 6331 (110th Congress): To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. In particular, execution of the kidney education and bundling provisions. H.R. 3200: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 3590: An act entitled The Patient Protection and Affordable Care Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. S. 1679: An original bill to make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce. S. 1796, "America's Healthy Future Act," An original bill to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes, as it relates to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. Drug and device marketing and promotion Drug and biological product pricing and reimbursement Healthcare-acquired infections Issues regarding 340B Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CREVISTON | — |
| JACK MANIKO | Counsel, House Cmte on Energy & Commerce |
| KELLI MILLS LESTER | — |
| JED PERRY | — |
| JOSEPH V SCHWAN | Deputy Chief of Staff, U.S. Dept of Commerce |
| DEBORAH WILLIAMS | — |
Taxation/Internal Revenue Code TAX
H.R. 3200, America's Affordable Health Choices Act of 2009/ "America's Healthy Future Act" (unnumbered Senate bill), as it relates to new fees on manufacturers of drugs and medical devices and to taxation of employer-sponsored health coverage. Issues related to the taxation of foreign earnings of U.S. multinational corporations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK MANIKO | Counsel, House Cmte on Energy & Commerce |
| JED PERRY | — |
| JOSEPH V SCHWAN | Deputy Chief of Staff, U.S. Dept of Commerce |
Copyright/Patent/Trademark CPT
S.515/S. 610/H.R. 1260: Patent Reform Act of 2009, all issues related to patent reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CREVISTON | — |
| JED PERRY | — |
| JOSEPH V SCHWAN | Deputy Chief of Staff, U.S. Dept of Commerce |
Medicare/Medicaid MMM
H.R. 3200: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. S. 301: A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP. H.R.1765 : To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. S.701: A bill to amend title XVIII of the Social Security Act to improve access of Medicare beneficiaries to intravenous immune globulins (IVIG). "America's Healthy Future Act" (unnumbered Senate bill), as it relates to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices. H.R. 6331 (110th Congress): To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. In particular, execution of the kidney education and bundling provisions. Product Payment Issues Therapy Payment Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CREVISTON | — |
| JACK MANIKO | Counsel, House Cmte on Energy & Commerce |
| KELLI MILLS LESTER | — |
| JED PERRY | — |
| JOSEPH V SCHWAN | Deputy Chief of Staff, U.S. Dept of Commerce |
| DEBORAH WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.